Medical Technology Breaking News: Aethlon Medical's (OTCBB: AEMD) Hemopurifier® Used in Successful Treatment of Patient with Advanced Ebola Infection

 

242 Million Copies of Ebola Virus Removed from Patient during Treatment, Physician Reports at American Society of Nephrology Annual Meeting

 

SAN DIEGO and PHILADELPHIA - November 14, 2014 (Investorideas.com newswire) The Aethlon Hemopurifier® was used in the ... Read more

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) Discloses Expanded Access "Emergency Use" Pathway to Treat Ebola in the United States

 

SAN DIEGO - November 19, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, disclosed today that it will provide Hemopurifier® ... Read more

Medical Technology Breaking News: Ebola Patient Who Received Aethlon (OTCBB: AEMD) Hemopurifier® Therapy Has Been Discharged From Hospital

 

SAN DIEGO - November 25, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, disclosed today that an Ebola patient who received Hemopurifier® ... Read more

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) Announces First Hemopurifier® Shipment To Support the Treatment of Ebola in the United States

 

SAN DIEGO - November 26, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, today announced the first shipment of ... Read more

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) Reports Rapid and Sustained Virologic Response Rates in Hepatitis C (HCV) Treated Patients

 

SAN DIEGO - December 2, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, today reported final clinical outcomes, including ... Read more

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) Initiates Patient Recruitment for FDA Approved Clinical Study

 

SAN DIEGO - December 11, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious diseases and cancer, today announced the initiation of patient recruitment to support a clinical ... Read more

Biotech News Alert: GenSpera (OTCQB:GNSZ) Live and Interactive Virtual Road Show on Dec 16th at 11:30 a.m. ET

 

December 15, 2014 (Investorideas.com Biotech Newswire) GenSpera, Inc. (OTCQB:GNSZ), a leader in developing innovative prodrug therapeutics for the treatment of cancer, announces its interactive virtual road show for interested investors.

 

GenSpera (Stock Symbol: GNSZ) ... Read more

Sports medicines refer to a branch of medicines that deal with treatment and prevention of the injuries and disorders that are caused by participation in sports and exercise. The U.S. has the largest market for sports medicines. This is due to high number of cases of sport injuries and raised awareness for these devices. Various devices such as splints and braces are used to safeguard the injured area. Implants such as artificial knee, meniscus and cartilage may be used for bone and ... Read more

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) Announces Approval of Ebola Treatment Protocol

 

SAN DIEGO - January 2, 2015 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious diseases and cancer, today announced that the United States Food and Drug Administration (FDA) has approved a ... Read more

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) to Present at Biotech Showcase 2015

 

SAN DIEGO - January 8, 2015 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious diseases and cancer, today announced that James A. Joyce, Chief Executive Officer, will present at the Biotech Showcase 2015 ... Read more

R&I: Prostate Cancer Treatment Drugs Markets in China

Reports and Intelligence adds a report on Prostate Cancer Treatment Drugs Markets in China. China's demand for Prostate Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.  Detailed report at:  http://www.reportsandintelligence.com/prostate-cancer-treatment-drugs-in-china-market  

The report firstly introduced Cervical Traction basic information included Cervical Traction definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Cervical Traction industry policy and plan, Cervical Traction product specification, manufacturing process, product cost structure etc.

Browse Complete Report with TOC ... Read more

Emerging Pharmaceuticals Markets in China

China's demand for Emerging Pharmaceuticals has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled Detailed report at:  http://www.reportsandintelligence.com/emerging-pharmaceuticals-in-china-market  

Global Cardiovascular Information System Market 2015-2019

A CVIS is a collection of research and clinical data gathered with the help of unique software, which facilitates information and support, and provides a complete medical record of patients in the cardiovascular field. The CVIS is used to endorse data with a high level of evidence-based quality. The CVIS improves patient safety and provides quality care by eliminating duplicate entries and reducing errors, besides improving efficiency. Detailed report at:  http://www.reportsandintelligence.com/global-cardiovascular-information-system-2015-2019-market  

According to a new market report published by Persistence Market Research “Global Market Study on Treatment for Syndromes of Dementia and Movement Disorders: Asia to Witness Highest Growth by 2020,” the global treatment for syndromes of dementia and movement disorders market was valued at USD 12,859.8 million in 2014 and is expected to grow at a CAGR of 8.6% from 2014 to 2020, to reach an estimated value of USD 21,154.8 million in 2020.

The treatment for syndromes of dementia and ... Read more

Asthma Treatment Drugs Markets in China

China's demand for Asthma Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Detailed report at:  http://www.reportsandintelligence.com/asthma-treatment-drugs-in-china-market  

R&I: United States Tissue Engineered Market - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2020

Reports and Intelligence adds a report on “United States Tissue Engineered - Skin Substitutes Market Outlook to 2020”. The report is designed with an aim to provide the market investors with full-fledged knowledge of the market trends and factors influencing the growth of the market.   Detailed report at: http://www.reportsandintelligence.com/united-states-tissue-engineered-skin-substitutes-outlook-to-2020-market The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Tissue Engineered - Skin Substitutes market wherever available.

Liver Cancer Treatment Drugs Markets in China

China's demand for Liver Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.  Detailed report at:  http://www.reportsandintelligence.com/liver-cancer-treatment-drugs-in-china-market  

Summary

Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The ... Read more

According to a new market report published by Persistence Market Research “Global Market Study on Disposable Plastic Blood Bags: Single Blood Bags to Witness Highest Growth by 2020” the global Disposable Plastic Blood Bags market was valued at USD 2,44,286.8 thousand in 2014 and is expected to grow at a CAGR of 9.1% from 2014 to 2020, to reach an estimated value of USD 4,13,084.8 thousand in 2020.

A disposable blood bag refers to a bio-medical device ... Read more

GlobalData’s new report, "United States Hyperbaric Oxygen Chambers Market Outlook to 2020", provides key market data on the United States Hyperbaric Oxygen Chambers market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Hyperbaric Oxygen Chambers (Monoplace and Multiplace Hyperbaric Oxygen Chambers).

The report also provides company shares and distribution shares data for each of these market ... Read more

Reports and Intelligence adds a report titled “Medical Technology Market in Europe 2014-2018.” The reports states that the medical technology market in the Europe region is expected to register a CAGR of 4.50% during the forecast period i.e. 2013-2018.

Medical technology consists of a wide variety of medical techniques and equipment, which are used to offer assistance to the patients with the entire medical process from disease diagnosis to treatment ... Read more

R&I: Global 3D Bioprinting Market 2014-2018

3D bioprinting is a process to produce tissues in a variety of formats from micro-scale tissues to standard multi-well tissues, where cell function and viability are preserved within the printed construct. A 3D bioprinter is a medical device used to regenerate human tissues, which are created by human cells. Detailed report at:  http://www.reportsandintelligence.com/global-3d-bioprinting-2014-2018-market    

ReportsnReports.com adds “Helicobacter Pylori Infections - Pipeline Review, H1 2015” to its store. This report provides comprehensive information on the therapeutic development for Helicobacter Pylori Infections, complete with comparative analysis at various stages.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report ... Read more

Asthma is a chronic inflammatory lung disease. Asthma affects personnel in all ages but mostly starts in childhood. Asthma creates inflammation in the inside walls of airways which makes airways very sensitive for the allergic reaction. Asthma may be caused due to genetic, environmental factors or combination of both. Almost all asthma sufferers have allergies. Some of the allergens are house dust mites in carpets, bedding and furniture, pet dander, pollens, moulds, air pollution, tobacco ... Read more

Global Markets Direct’s, ‘Diarrhea - Pipeline Review, H1 2015’, provides an overview of the Diarrhea’s therapeutic pipeline.            

This report provides comprehensive information on the therapeutic development for Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press ... Read more

Global Markets Direct’s, ‘Atrial Fibrillation - Pipeline Review, H1 2015’, provides an overview of the Atrial Fibrillation’s therapeutic pipeline.

 

This report provides comprehensive information on the therapeutic development for Atrial Fibrillation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press ... Read more

ReportsnReports.com adds “Obsessive-Compulsive Disorder - Pipeline Review, H1 2015” to its store. This report provides comprehensive information on the therapeutic development for Obsessive-Compulsive Disorder, complete with comparative analysis at various stages.

Global Markets Direct’s, ‘Obsessive-Compulsive Disorder - Pipeline Review, H1 2015’, provides an overview of the Obsessive-Compulsive Disorder’s ... Read more

ReportsnReports.com adds “Nerve Injury - Pipeline Review, H1 2015” to its store. This report provides comprehensive information on the therapeutic development for Nerve Injury, complete with comparative analysis at various stages.

Global Markets Direct’s, ‘Nerve Injury - Pipeline Review, H1 2015’, provides an overview of the Nerve Injury’s therapeutic pipeline.

... Read more

Medical Technology Breaking News: Aethlon Medical, Inc. (OTCBB: AEMD) - The Launch of a Clinical Program That Re-Thinks the Treatment of Viral Pathogens

 

SAN DIEGO - February 5, 2015 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), today published an article on The Chairman's Blog, written by the Company's Chairman and CEO, Jim Joyce. TheChairmansBlog.com is an exclusive online ... Read more

Pages